DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1NanoAlvand
03 2medac
04 2ATNAHS PHARMA UK LIMITED
05 2Abcur Ab
06 19Adienne
07 2Amgen Inc
08 2Beloteca
09 4Esteve Quimica
10 4Fresenius Kabi AB Brunna
11 1Fresenius Kabi USA
12 2GLAND PHARMA LIMITED
13 1GetWell Pharmaceutical
14 3Hikma Pharmaceuticals
15 1Jiangsu Hengrui Medicine
16 2MIKLICH LABORATORIOS S.L.
17 2MSN Laboratories
18 1Meda Ab
19 2Meitheal Pharmaceuticals
20 1Penn Life Sciences
21 2SEACROSS PHARMACEUTICALS
22 2STERIMAX INC
23 2Shorla Oncology
24 2Teva Pharmaceutical Industries
25 2TherDose Pharma
26 2Tobio Novelfarma
27 2Vivanta Generics Sro
28 1West-ward Pharmaceutical Corp
01 10INJECTABLE;INJECTION
02 3Injection
03 2Lyophilized Powder for Injectable Solution
04 7POWDER FOR SOLUTION
05 10POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
06 1POWDER;INTRAVENOUS
07 1Powder And Solvent For Infusion Solution
08 2Powder For Concentrate For Infusion Solution
09 20Powder For Concentrate For Solution For Infusion
10 2Powder to concentrate to the infusion fluid, resolution
11 2SOLUTION;INTRAVENOUS
12 2Solution For Infusion
13 5Solution For Injection
14 1Thiotepa 100Mg 10Ml 1 Units Parenteral Use
15 1Thiotepa 15Mg 1.5 Ml 1 Units Parenteral Use
16 1Vial
01 4Allowed
02 14Approved
03 11Authorized
04 5DISCN
05 1Deregistered
06 7Prescription
07 18RX
08 10Blank
01 7TEPADINA
02 1TEPADINA AND SODIUM CHLORIDE
03 2TEPASYL
04 1TEPAWEL
05 2TEPYLUTE
06 1THIOPLEX
07 17THIOTEPA
08 2THIOTEPA FOR INJECTION USP
09 2THIOTEPA FOR INJECTION, BP
10 2THIOTHER
11 2Tepa Dina
12 11Tepadina
13 2Thionovia
14 1Thiotepa
15 2Thiotepa Abcur
16 2Thiotepa Fresenius Kabi
17 2Thiotepa Medac
18 4Thiotepa Riemser
19 2Thiotepa Vivanta
20 1Tinopa
21 2Tiotepa Kabi
22 2Tiotepa Seacross
01 7Canada
02 3India
03 1Iran
04 2Italy
05 2Norway
06 11Spain
07 15Sweden
08 4Switzerland
09 2Turkey
10 23USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2018-05-04
Application Number : 210337
Regulatory Info : RX
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Tinopa
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Thiotepa Medac
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 100mg
Packaging :
Approval Date : 06/03/2023
Application Number : 20220902000081
Regulatory Info : Approved
Registration Country : Sweden
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Thiotepa Medac
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 15mg
Packaging :
Approval Date : 06/03/2023
Application Number : 20220902000074
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : TEPADINA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2017-01-26
Application Number : 208264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TEPADINA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2017-01-26
Application Number : 208264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TEPADINA AND SODIUM CHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 200MG
Packaging :
Approval Date : 2025-04-10
Application Number : 208264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 1982-01-01
Application Number : 11683
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOPLEX
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-22
Application Number : 20058
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2021-12-08
Application Number : 211831
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2001-09-20
Application Number : 75698
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2021-03-08
Application Number : 214222
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-09-05
Application Number : 211755
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2018-05-04
Application Number : 209150
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2020-03-04
Application Number : 213049
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2020-03-04
Application Number : 213049
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2020-01-10
Application Number : 208242
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-04-20
Application Number : 75730
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-04-20
Application Number : 75730
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : THIOTEPA
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 15MG/VIAL
Packaging :
Approval Date : 2001-04-02
Application Number : 75547
Regulatory Info : RX
Registration Country : USA
